Johnson & Johnson (JNJ) Business News

Track Johnson & Johnson in real time with a live news feed covering Johnson & Johnson stock news, official press releases, company announcements, and an archive of historical Johnson & Johnson news. ...more

  • Calendar
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
10:27 AM | Saturday | May 23, 2026 247 Wallst

The Single Premium Immediate Annuity That Adds $3,800 a Month to a $1.2 Million Income Portfolio Without Touching a Stock

News Thumbnail
10:27 AM | Saturday | May 23, 2026 247 Wallst

The Single Premium Immediate Annuity That Adds $3,800 a Month to a $1.2 Million Income Portfolio Without Touching a Stock

News Thumbnail
11:05 AM | Friday | May 22, 2026 Zacks Investment Research

J&J & Pfizer Face Patent Risks: Which Stock Looks Better Positioned?

News Thumbnail
7:36 AM | Friday | May 22, 2026 24/7 Wall Street

The Dividend Stocks That Can Replace a $65,000 Income and What They'll Cost You

News Thumbnail
7:15 AM | Friday | May 22, 2026 24/7 Wall Street

Six Boring Blue Chips Generate $54,000 a Year on $920,000 Without a Single 7 Percent Yield Trap

News Thumbnail
7:00 AM | Thursday | May 21, 2026 Business Wire

Johnson & Johnson Advances Creation of Global Intelligent OR Network in collaboration with Department of Health - Abu Dhabi

News Thumbnail
4:31 AM | Thursday | May 21, 2026 Reuters

Johnson & Johnson says nipocalimab approved in China

News Thumbnail
12:54 PM | Wednesday | May 20, 2026 Seeking Alpha

FQ1 Healthcare Dividend Roundup: Johnson & Johnson Keeps Outshining Pfizer

News Thumbnail
11:32 AM | Wednesday | May 20, 2026 247 Wallst

How Much Do You Really Need Invested to Replace a $40,000 Salary at 62 and Bridge the Five Years Until Social Security at 67?

News Thumbnail
12:21 PM | Tuesday | May 19, 2026 Zacks Investment Research

J&J's Pipeline Progress & New Drugs Promise Stronger Long-Term Growth

News Thumbnail
10:21 AM | Tuesday | May 19, 2026 24/7 Wall Street

This Will Be Johnson and Johnson's Stock Price in 2027

News Thumbnail
news photo
Loading...

A 73-year-old retiree with a $1.2 million dividend portfolio generating $5,400 a month faces a quieter retirement problem than most. The income works, but it depends on corporations continuing to pay and raise dividends for another 20 to 25 years. Shifting $500,000 into a Single Premium Immediate Annuity (SPIA) replaces part of that market dependence..
. The Single Premium Immediate Annuity That Adds $3,800 a Month to a $1.2 Million Income Portfolio Without Touching a Stock

Read full article redirect
10:27 AM | Saturday | May 23, 2026

The Single Premium Immediate Annuity That Adds $3,800 a Month to a $1.2 Million Income Portfolio Without Touching a Stock

247 Wallst

A 73-year-old retiree with a $1.2 million dividend portfolio generating $5,400 a month faces a quieter retirement problem than most. The income works, but it depends on corporations continuing to pay and raise dividends for another 20 to 25 years. Shifting $500,000 into a Single Premium Immediate Annuity (SPIA) replaces part of that market dependence..
. The Single Premium Immediate Annuity That Adds $3,800 a Month to a $1.2 Million Income Portfolio Without Touching a Stock

Read full article arrow
News Thumbnail
10:27 AM | Saturday | May 23, 2026

The Single Premium Immediate Annuity That Adds $3,800 a Month to a $1.2 Million Income Portfolio Without Touching a Stock

247 Wallst

A 73-year-old retiree with a $1.2 million dividend portfolio generating $5,400 a month faces a quieter retirement problem than most. The income works, but it depends on corporations continuing to pay and raise dividends for another 20 to 25 years. Shifting $500,000 into a Single Premium Immediate Annuity (SPIA) replaces part of that market dependence..
. The Single Premium Immediate Annuity That Adds $3,800 a Month to a $1.2 Million Income Portfolio Without Touching a Stock

Read full article arrow
News Thumbnail
11:05 AM | Friday | May 22, 2026

J&J & Pfizer Face Patent Risks: Which Stock Looks Better Positioned?

Zacks Investment Research

JNJ's diversified pharma and MedTech growth, pipeline progress and stronger 2026 outlook give it an edge over PFE.

Read full article arrow
News Thumbnail
7:36 AM | Friday | May 22, 2026

The Dividend Stocks That Can Replace a $65,000 Income and What They'll Cost You

24/7 Wall Street

Dividend-growth blue chips like Coca-Cola double income in nine years despite lower starting yields, while high-yield BDCs and REITs with frozen payouts risk delivering less income over a decade than lower-yield growers.

Read full article arrow
News Thumbnail
7:15 AM | Friday | May 22, 2026

Six Boring Blue Chips Generate $54,000 a Year on $920,000 Without a Single 7 Percent Yield Trap

24/7 Wall Street

The six names below sit firmly in the conservative-to-moderate tier. Five are Dividend Kings or Aristocrats.

Read full article arrow
News Thumbnail
7:00 AM | Thursday | May 21, 2026

Johnson & Johnson Advances Creation of Global Intelligent OR Network in collaboration with Department of Health - Abu Dhabi

Business Wire

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson today announced a collaboration with the Department of Health – Abu Dhabi (DOH), the regulator of the healthcare sector in Abu Dhabi, UAE, launching a global program to develop an open surgical intelligence network— establishing Abu Dhabi as the first node in a global infrastructure designed to accelerate artificial intelligence (AI) innovation for every stage of the surgery experience. Integrating Johnson & Johnson's Polyphonic™ o.

Read full article arrow
News Thumbnail
4:31 AM | Thursday | May 21, 2026

Johnson & Johnson says nipocalimab approved in China

Reuters

Johnson & ‌Johnson's nipocalimab ​has ​won ⁠approval ​in China, ​the U.S. ​drugmaker ​said on ‌its ⁠WeChat social ​media ​account ⁠Thursday.

Read full article arrow
News Thumbnail
12:54 PM | Wednesday | May 20, 2026

FQ1 Healthcare Dividend Roundup: Johnson & Johnson Keeps Outshining Pfizer

Seeking Alpha

Johnson & Johnson offers a superior return/risk profile versus Pfizer, driven by consistency and operational stability. PFE's far lower valuation (FWD P/E 8.55x, PEGY 0.97x) and far higher yield (6.79%) are certainly attractive.
But JNJ's 63-year streak of dividend growth, lower payout ratio (48.46%), ongoing buybacks, and stable inventory all point to far superior consistency.

Read full article arrow
News Thumbnail
11:32 AM | Wednesday | May 20, 2026

How Much Do You Really Need Invested to Replace a $40,000 Salary at 62 and Bridge the Five Years Until Social Security at 67?

247 Wallst

A $40,000 annual income is often enough for a 62-year-old retiree living modestly while bridging the five years until full Social Security benefits begin at 67. The challenge is generating that income entirely from dividends without selling shares or steadily drawing down principal. The core equation is simple: divide the target income by the portfolio's yield...
How Much Do You Really Need Invested to Replace a $40,000 Salary at 62 and Bridge the Five Years Until Social Security at 67?

Read full article arrow
News Thumbnail
12:21 PM | Tuesday | May 19, 2026

J&J's Pipeline Progress & New Drugs Promise Stronger Long-Term Growth

Zacks Investment Research

J&J's expanding pipeline, new drug approvals and rising sales from cancer medicines are expected to fuel growth.

Read full article arrow
News Thumbnail
10:21 AM | Tuesday | May 19, 2026

This Will Be Johnson and Johnson's Stock Price in 2027

24/7 Wall Street

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) closed the most recent session at $230.42, up 2.58% on the week as buyers rotated back into

Read full article arrow
News Thumbnail